Evercore ISI Group Maintains Outperform on CVS Health, Lowers Price Target to $125

Benzinga Newsdesk www.benzinga.com Negative 94.4%

Neg 94.4% Neu 0% Pos 0%

Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $130 to $125.